MCAM and neoplasm: Possible correlations among peripheral molecular monitoring and immunohistochemical MCAM/MUC18 staining on corresponding primary neoplasms, primary tumour thickness, AJCC stage and clinical outcome will be investigated in order to suggest additional tools of stratification and/or distinction for tumour progression.